SCHEMBL6158503

SCHEMBL6158503

CCC(O)CO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP2D6 P10635 1/20 0.36
SMYD2 Q9NRG4 2/20 0.35
LMNA P02545 2/20 0.35
KMT2A Q03164 2/20 0.34
SLC18A3 Q16572 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
ADRB2 P07550 1/20 0.33
ADRB1 P08588 1/20 0.33
ADRB3 P13945 1/20 0.33
TSHR P16473 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
KDM4E B2RXH2 1/20 0.32
AGTR1 P30556 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24312400 0.92 CYP2D6 (0.38) CYP3A4HTTSMN1; SMN2CYP2D6SMYD2
SCHEMBL7155286 0.90 CYP2D6 (0.37) CYP3A4HTTSMN1; SMN2CYP2D6SMYD2
SCHEMBL21873649 0.89 CYP1A2 (0.42) CYP3A4HTTSMN1; SMN2CYP2D6LMNA
SCHEMBL218117 0.89 CYP1A2 (0.42) CYP3A4HTTSMN1; SMN2CYP2D6LMNA
SCHEMBL2531862 0.89 CYP1A2 (0.42) CYP3A4HTTSMN1; SMN2CYP2D6LMNA
SCHEMBL30335638 0.88 CYP2D6 (0.34) CYP3A4HTTSMN1; SMN2CYP2D6SMYD2
SCHEMBL19067469 0.87 SMYD2 (0.32) CYP3A4HTTSMN1; SMN2SMYD2TSHR
SCHEMBL15209482 0.86 ALOX15 (0.44) CYP3A4HTTSMN1; SMN2CYP2D6KMT2A
SCHEMBL15209484 0.86 ALOX15 (0.44) CYP3A4HTTSMN1; SMN2CYP2D6KMT2A
SCHEMBL6156817 0.86 AR (0.41) CYP3A4HTTSMN1; SMN2CYP2D6SMYD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9845308-B2 Isoindoline inhibitors of ROR-gamma VITAE PHARMACEUTICALS, INC. (US) 2017-12-19 US disclosed
US-20160122318-A1 ISOINDOLINE INHIBITORS OF ROR-GAMMA VITAE PHARMACEUTICALS, LLC 2016-05-05 US disclosed
US-7388002-B2 Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases BIOCRYST PHARMACEUTICALS, INC. (US) 2008-06-17 US disclosed
EP-1505156-B1 Process for the enantioselective preparation of secondary alcohols by lipase catalysed solvolysis of the corresponding acetoacetic acid ester CONSORTIUM ELEKTROCHEM IND (DE) 2005-12-07 EP disclosed
US-20050032182-A1 Process for the enantioselective preparation of secondary alcohols by lipase-catalyzed solvolysis of the corresponding acetoacetic esters CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH 2005-02-10 US disclosed
EP-1505156-A1 Process for the enantioselective preparation of secondary alcohols by lipase catalysed solvolysis of the corresponding acetoacetic acid ester Consortium für elektrochemische Industrie GmbH (DE) 2005-02-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160122318-A1 ISOINDOLINE INHIBITORS OF ROR-GAMMA RORC, RORB, RORA CYP3A4 245/4885HTT 4678/4885SMN1; SMN2 3819/4885
US-20050032182-A1 Process for the enantioselective preparation of secondary alcohols by lipase-catalyzed solvolysis of the corresponding acetoacetic esters LIPC, LIPE, LIPA CYP3A4 698/4885HTT 4371/4885SMN1; SMN2 3012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.